ResearcherUniversity of Kansas Medical CenterActive in the last 2 years
Tao Wang
Matched on ORCID iD 0000-0003-4832-1148; OpenAlex author ID A5100453721. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 5
- A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. Co-author DOI 10.1186/s13046-025-03389-5↗
- Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly. Co-author DOI 10.3389/fonc.2022.870473↗
- Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice. Co-author DOI 10.3389/fonc.2021.773350↗
- An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells. Co-author DOI 10.1158/1535-7163.mct-19-0822↗
- Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation. Co-author DOI 10.1371/journal.pone.0164811↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruochen Dong · 3 shared papers, 2016–2021 · strength 0.32
- Paper Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice. DOI 10.3389/fonc.2021.773350↗
- Paper An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer… DOI 10.1158/1535-7163.mct-19-0822↗
- Paper Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tu… DOI 10.1371/journal.pone.0164811↗
- Ping Chen · 2 shared papers, 2016–2022 · strength 0.25
- Qi Chen · 2 shared papers, 2016–2021 · strength 0.21
- Paper Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice. DOI 10.3389/fonc.2021.773350↗
- Paper Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tu… DOI 10.1371/journal.pone.0164811↗
- Juliana Calheiros · 1 shared paper, 2025 · strength 0.20
- Vincenzo Corbo · 1 shared paper, 2025 · strength 0.20
- Lucı́lia Saraiva · 1 shared paper, 2025 · strength 0.20
- Elena Fiorini · 1 shared paper, 2025 · strength 0.20
- Sónia A. Melo · 1 shared paper, 2025 · strength 0.20
- Qi Chen · 1 shared paper, 2022 · strength 0.19
- Kishore Polireddy · 2 shared papers, 2016–2020 · strength 0.17
- Paper An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer… DOI 10.1158/1535-7163.mct-19-0822↗
- Paper Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tu… DOI 10.1371/journal.pone.0164811↗
- Liang Xu · 1 shared paper, 2020 · strength 0.11
- Qi Chen · 1 shared paper, 2020 · strength 0.11
- Xiaoqing Wu · 1 shared paper, 2020 · strength 0.11
- Dan A. Dixon · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.